Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05013008
What this trial is testing

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 951
Not applicableNot Yet RecruitingNCT07266220
What this trial is testing

Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.

Who this might be right for
Diabetes Mellitus, Type 2Chronic Kidney DiseaseAtherosclerosis
Abdallah Ali Mohammed 96
Not applicableUnknownNCT06069518
What this trial is testing

Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis

Who this might be right for
Kidney Disease, ChronicPeritoneal DialysisDiabetes Mellitus Type 2
Coordinación de Investigación en Salud, Mexico 110
Post-approval studies (Phase 4)Study completedNCT06094920
What this trial is testing

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Who this might be right for
Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus, Type 2Diabetes Mellitus+10 more
University Medical Center Groningen 12
Not applicableUnknownNCT01792206
What this trial is testing

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Who this might be right for
Type 2 DiabetesChronic Kidney Disease
Scott and White Hospital & Clinic 60
Large-scale testing (Phase 3)UnknownNCT03262363
What this trial is testing

Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2Polymorphism
Unidad de Investigacion Medica en Enfermedades Renales 176
Not applicableLooking for participantsNCT03457168
What this trial is testing

Treatment of Hypertension During Sleep

Who this might be right for
HypertensionHypertension, Systolic
University of Vigo 5,320
Not applicableWithdrawnNCT00849316
What this trial is testing

Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S
Not applicableStudy completedNCT02587936
What this trial is testing

Improving Chronic Disease Management With Pieces

Who this might be right for
Chronic Kidney DiseaseDiabetesHypertension+2 more
University of Texas Southwestern Medical Center 18,268
Not applicableStudy completedNCT07719621
What this trial is testing

Evaluation of the Risk of Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Who this might be right for
CKD - Chronic Kidney DiseaseDiabetes Mellitus Type 2
Aeterna Medical Solutions SL 100,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Testing effectiveness (Phase 2)Study completedNCT00811889
What this trial is testing

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesDiabetic Nephropathy
Biogen 227
Testing effectiveness (Phase 2)Study completedNCT05570305
What this trial is testing

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Who this might be right for
Chronic Kidney Diseases
University Medical Center Groningen 42
Not applicableActive Not RecruitingNCT04791358
What this trial is testing

Decision Impact Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney Disease
Renalytix AI, Inc. 1,500
Early research (Phase 1)Ended earlyNCT03840343
What this trial is testing

Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathiesDiabetes Mellitus, Type 2+5 more
Mayo Clinic 2
Not applicableStudy completedNCT05781334
What this trial is testing

Optimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic Disease

Who this might be right for
Heart FailureType 2 DiabetesChronic Kidney Diseases
Duke University 202
Testing effectiveness (Phase 2)UnknownNCT04769687
What this trial is testing

Symbiotics and Systemic Inflammation in Chronic Kidney Disease

Who this might be right for
Chronic Renal FailureDiabete Type 2Systemic Inflammation
Centre Hospitalier Universitaire de Besancon 62
Testing effectiveness (Phase 2)Ended earlyNCT01574365
What this trial is testing

RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 53
Large-scale testing (Phase 3)Study completedNCT01698775
What this trial is testing

Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 213
Post-approval studies (Phase 4)Not Yet RecruitingNCT07704190
What this trial is testing

Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease

Who this might be right for
Cardiorenal Metabolic SyndromeAtherosclerotic Cardiovascular DiseaseChronic Kidney Disease+5 more
Peking University Third Hospital 100
Next Page